Drug Trial Radar · NCT04889677
Study of a Single Dose of Danicopan in Healthy Participants
Last checked: Nov 20, 2026Latest source record: May 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Feb 4, 2016
Primary completion
Jun 21, 2016
Study completion Jun 21, 2016
Sponsor
- Lead sponsor
- Alexion Pharmaceuticals, Inc.AstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Achillion, a wholly owned subsidiary of Alexion
- First posted
- May 17, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 21 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This was a single ascending dose, randomized, double-blind study assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of danicopan in healthy participants. Four different doses (200 milligrams \[mg\], 600 mg, 1200 mg, 2400 mg) and dose-matched placebo were administered under fasted and fed conditions.
Conditions
- Healthy
Interventions
DanicopanDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Of Serious Adverse Events, Grade 3 Or 4 Adverse Events (AEs), AEs Leading To Discontinuation, And Clinically Significant Laboratory Abnormalities And Electrocardiogram AbnormalitiesTime frame: Day 1 through Day 28
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinical Trial Site
Auckland, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.